Literature DB >> 30561690

Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies.

Brendan Flannery1, Alicia M Fry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30561690      PMCID： PMC9295181          DOI： 10.1093/infdis/jiy717

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   7.759


× No keyword cloud information.
  11 in total

1.  The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.

Authors:  P G Van Buynder; S Konrad; J L Van Buynder; E Brodkin; M Krajden; G Ramler; M Bigham
Journal:  Vaccine       Date:  2013-08-06       Impact factor: 3.641

2.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.

Authors:  David K Shay; Yoganand Chillarige; Jeffrey Kelman; Richard A Forshee; Ivo M Foppa; Michael Wernecke; Yun Lu; Jill M Ferdinands; Arjun Iyengar; Alicia M Fry; Chris Worrall; Hector S Izurieta
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

3.  Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.

Authors:  Lisa M Dunkle; Ruvim Izikson; Peter Patriarca; Karen L Goldenthal; Derek Muse; Janice Callahan; Manon M J Cox
Journal:  N Engl J Med       Date:  2017-06-22       Impact factor: 91.245

4.  Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.

Authors:  Hector S Izurieta; Yoganand Chillarige; Jeffrey Kelman; Yuqin Wei; Yun Lu; Wenjie Xu; Michael Lu; Douglas Pratt; Steve Chu; Michael Wernecke; Thomas MaCurdy; Richard Forshee
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

Review 5.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

Authors:  Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean
Journal:  Lancet Infect Dis       Date:  2016-04-06       Impact factor: 25.071

6.  Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

Authors:  Carlos A DiazGranados; Andrew J Dunning; Murray Kimmel; Daniel Kirby; John Treanor; Avi Collins; Richard Pollak; Janet Christoff; John Earl; Victoria Landolfi; Earl Martin; Sanjay Gurunathan; Richard Nathan; David P Greenberg; Nadia G Tornieporth; Michael D Decker; H Keipp Talbot
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

Review 7.  Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

Authors:  Marc Rondy; Nathalie El Omeiri; Mark G Thompson; Alain Levêque; Alain Moren; Sheena G Sullivan
Journal:  J Infect       Date:  2017-09-18       Impact factor: 6.072

8.  Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.

Authors:  Hector S Izurieta; Nicole Thadani; David K Shay; Yun Lu; Aaron Maurer; Ivo M Foppa; Riley Franks; Douglas Pratt; Richard A Forshee; Thomas MaCurdy; Chris Worrall; Andrew E Howery; Jeffrey Kelman
Journal:  Lancet Infect Dis       Date:  2015-02-09       Impact factor: 25.071

9.  Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Authors:  Seth J Zost; Kaela Parkhouse; Megan E Gumina; Kangchon Kim; Sebastian Diaz Perez; Patrick C Wilson; John J Treanor; Andrea J Sant; Sarah Cobey; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

10.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2018-08-24
View more
  3 in total

1.  Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States.

Authors:  Constantina Boikos; Lauren Fischer; Dan O'Brien; Joe Vasey; Gregg C Sylvester; James A Mansi
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

Review 2.  [High-dose trivalent influenza vaccine. Efficacy and effectiveness].

Authors:  A Gil de Miguel; E Redondo Marguello; J Díez Domingo; R Ortiz de Lejarazu; F Martinón Torres
Journal:  Rev Esp Quimioter       Date:  2020-06-09       Impact factor: 1.553

3.  Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus.

Authors:  Yong Wook Park; Yun Hee Kim; Hwan Ui Jung; Oh Seok Jeong; Eun Ji Hong; Hun Kim; Jae Il Lee
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.